Pretraga

Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1277251

Influence of ovarian function supression on quality of life in breast cancer survivors during adjuvant endocrine therapy.

Dedić Plavetić, Natalija; Dugonjić Okroša, Ana; Silovski, Tajana; Jović Zlatović, Josipa; Jajac Bručić, Lana; Skelin, Marko; Mucalo, Iva
Influence of ovarian function supression on quality of life in breast cancer survivors during adjuvant endocrine therapy. // Journal of Clinical Oncology
Chicago (IL), Sjedinjene Američke Države, 2023. 560, 1 doi:10.1200/JCO.2023.41.16_suppl.560 (poster, međunarodna recenzija, sažetak, znanstveni)

CROSBI ID: 1277251 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Influence of ovarian function supression on quality of life in breast cancer survivors during adjuvant endocrine therapy.

Autori
Dedić Plavetić, Natalija ; Dugonjić Okroša, Ana ; Silovski, Tajana ; Jović Zlatović, Josipa ; Jajac Bručić, Lana ; Skelin, Marko ; Mucalo, Iva

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Journal of Clinical Oncology / - , 2023

Skup
ASCO 2023 American Society of Clinical Oncology Annual Meeting

Mjesto i datum
Chicago (IL), Sjedinjene Američke Države, 02.06.2023. - 06.06.2023

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
early breast cancer (EBC), ovarian function suppression, adjuvant endocrine therapy

Sažetak
Adding ovarian function suppression to adjuvant endocrine therapy (AET) lowers the disease recurrence rates among premenopausal women with hormone receptor-positive (HR+) early breast cancer (EBC). However, a detrimental effect on endocrine symptoms burden (ESB) is expected. Therefore, this study aimed to investigate differences in Quality of life (QoL) and endocrine symptoms in premenopausal women prescribed AET, with/without gonadotropin- releasing hormone agonist (GnRH).This study showed that GnRH+AI in premenopausal women with HR+ EBC results in greater ESB and lower QoL compared to patients treated with TAM or GnRH+TAM. Therefore, interventions helping decrease the ESB in patients treated with AI+GnRH should be explored and developed to help patients adhere to and persist in AET.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA

Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Medicinski fakultet, Zagreb,
Opća bolnica Šibenik,
Klinički bolnički centar Zagreb

Profili:

Avatar Url Marko Skelin (autor)

Avatar Url Lana Jajac Bručić (autor)

Avatar Url Iva Mucalo (autor)

Avatar Url Ana Dugonjić Okroša (autor)

Avatar Url Natalija Dedić-Plavetić (autor)

Avatar Url Tajana Silovski (autor)

Poveznice na cjeloviti tekst rada:

doi meetings.asco.org

Citiraj ovu publikaciju:

Dedić Plavetić, Natalija; Dugonjić Okroša, Ana; Silovski, Tajana; Jović Zlatović, Josipa; Jajac Bručić, Lana; Skelin, Marko; Mucalo, Iva
Influence of ovarian function supression on quality of life in breast cancer survivors during adjuvant endocrine therapy. // Journal of Clinical Oncology
Chicago (IL), Sjedinjene Američke Države, 2023. 560, 1 doi:10.1200/JCO.2023.41.16_suppl.560 (poster, međunarodna recenzija, sažetak, znanstveni)
Dedić Plavetić, N., Dugonjić Okroša, A., Silovski, T., Jović Zlatović, J., Jajac Bručić, L., Skelin, M. & Mucalo, I. (2023) Influence of ovarian function supression on quality of life in breast cancer survivors during adjuvant endocrine therapy.. U: Journal of Clinical Oncology doi:10.1200/JCO.2023.41.16_suppl.560.
@article{article, author = {Dedi\'{c} Plaveti\'{c}, Natalija and Dugonji\'{c} Okro\v{s}a, Ana and Silovski, Tajana and Jovi\'{c} Zlatovi\'{c}, Josipa and Jajac Bru\v{c}i\'{c}, Lana and Skelin, Marko and Mucalo, Iva}, year = {2023}, pages = {1}, DOI = {10.1200/JCO.2023.41.16\_suppl.560}, chapter = {560}, keywords = {early breast cancer (EBC), ovarian function suppression, adjuvant endocrine therapy}, doi = {10.1200/JCO.2023.41.16\_suppl.560}, title = {Influence of ovarian function supression on quality of life in breast cancer survivors during adjuvant endocrine therapy.}, keyword = {early breast cancer (EBC), ovarian function suppression, adjuvant endocrine therapy}, publisherplace = {Chicago (IL), Sjedinjene Ameri\v{c}ke Dr\v{z}ave}, chapternumber = {560} }
@article{article, author = {Dedi\'{c} Plaveti\'{c}, Natalija and Dugonji\'{c} Okro\v{s}a, Ana and Silovski, Tajana and Jovi\'{c} Zlatovi\'{c}, Josipa and Jajac Bru\v{c}i\'{c}, Lana and Skelin, Marko and Mucalo, Iva}, year = {2023}, pages = {1}, DOI = {10.1200/JCO.2023.41.16\_suppl.560}, chapter = {560}, keywords = {early breast cancer (EBC), ovarian function suppression, adjuvant endocrine therapy}, doi = {10.1200/JCO.2023.41.16\_suppl.560}, title = {Influence of ovarian function supression on quality of life in breast cancer survivors during adjuvant endocrine therapy.}, keyword = {early breast cancer (EBC), ovarian function suppression, adjuvant endocrine therapy}, publisherplace = {Chicago (IL), Sjedinjene Ameri\v{c}ke Dr\v{z}ave}, chapternumber = {560} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE

Citati:

    Altmetrijski pokazatelji:


    Podijeli:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font
    CROSBI koristi kolačiće (cookies) kako bi poboljšao funkcionalnost stranice.